Allspring Global Investments’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
SCM
BI
AC
ACM
Allspring Global Investments's KURA Position: Q2 2026 in Review
Allspring Global Investments increased its Kura Oncology (KURA) stake by 3.8% in Q2 2026, buying an estimated $8.4K and bringing the position to 24,187 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.
Allspring Global Investments first reported a position in KURA in Q3 2022 and has held it in 9 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- Allspring Global Investments held 24,187 shares of Kura Oncology worth $261K as of Q2 2026.
- Allspring Global Investments bought 890 Kura Oncology shares in Q2 2026, an estimated $8.4K.
- Kura Oncology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1606 holding.
- Allspring Global Investments first reported a position in Kura Oncology in Q3 2022 and has held it in 9 quarters since.
- 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.